Cornulin as a Key Diagnostic and Prognostic Biomarker in Cancers of the Squamous Epithelium
Genes · 2024
DOI: 10.3390/genes15091122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, 2024. Verfasst von Varun Shankavaram und 4 weiteren Autor:innen. Beteiligte Einrichtung: Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The prevalence of squamous cell carcinoma is increasing, and efforts that aid in an early and accurate diagnosis are crucial to improve clinical outcomes for patients. Cornulin, a squamous epithelium-specific protein, has recently garnered attention due to its implications in the progression of squamous cell carcinoma developed in several tissues. As an epidermal differentiation marker, it is involved in skin anchoring, regulating cellular proliferation, and is a putative tumor suppressor. The physiologically healthy squamous epithelium displays a considerable level of Cornulin, whereas squamous cell carcinomas have marked downregulation, suggesting that Cornulin expression levels can be utilized for the early detection and follow-up on the progression of these types of cancer. Cornulin’s expression patterns in cervical cancer have been examined, and findings support the stepwise downregulation of Cornulin levels that accompanies the progression to neoplasia in the cervix. Additional studies documented a similar trend in expression in other types of cancer, such as cutaneous, esophageal, and oropharyngeal squamous cell carcinomas. The consistent and predictable pattern of Cornulin expression across several squamous cell carcinomas and its correlation with key clinicopathological parameters make it a reliable biomarker for assessing the transformation and progression events in the squamous epithelium, thus potentially contributing to the early detection, definitive diagnosis, and more favorable prognosis for these cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL 60515, USA.
- Public Health Program, College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA.
- Department of Internal Medicine, Swedish Covenant Hospital, Chicago, IL 60625, USA.
- Department of Pathology, College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA.
- Precision Medicine Program, College of Graduate Studies, Midwestern University, Downers Grove, IL 60515, USA.
- Chicago College of Optometry, Midwestern University, Downers Grove, IL 60515, USA.
ORCID-Profile: Hilal Arnouk
Zitieren
APA
Shankavaram, V., Shah, D., Alashqar, A., Sweeney, J., & Arnouk, H. (2024). Cornulin as a Key Diagnostic and Prognostic Biomarker in Cancers of the Squamous Epithelium. Genes. https://doi.org/10.3390/genes15091122
Vancouver
Shankavaram V, Shah D, Alashqar A, Sweeney J, Arnouk H. Cornulin as a Key Diagnostic and Prognostic Biomarker in Cancers of the Squamous Epithelium. Genes. 2024. doi:10.3390/genes15091122
BibTeX
@article{Shankavaram2024,
author = {Shankavaram, Varun and Shah, Dean and Alashqar, Aseel and Sweeney, Jackson and Arnouk, Hilal},
title = {Cornulin as a Key Diagnostic and Prognostic Biomarker in Cancers of the Squamous Epithelium},
journal = {Genes},
year = {2024},
doi = {10.3390/genes15091122}
}
EUVIMED